For the Inventor, By the Inventor

Enter assignee name

Villepinte, France

Guerbet S.a.

USPTO Granted Patents = 25

Trademarks = 2

Forward Citations = 263

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Dominique Meyer (19 out of 24 patents)

Michel Schaefer (6 out of 7 patents)

Bruno Bonnemain (5 out of 8 patents)

4. Christian Simonot (5 out of 7 patents)

5. Olivier Rousseaux (4 out of 13 patents)

6. Didier Doucet (4 out of 5 patents)

7. Jean Lautrou (4 out of 10 patents)

8. Soizic Le Greneur (3 out of 7 patents)

9. Dominique Paris (3 out of 4 patents)

10. Maryse Dugast-Zrihen (3 out of 3 patents)

11. Gael Le Lem (3 out of 3 patents)

12. Charles T Harding (2 out of 2 patents)

13. Guy Tilly (2 out of 8 patents)

14. Bernard F Spielvogel (1 out of 27 patents)

15. Michel Guillemot (1 out of 1 patent)

Core Competencies:

Polyaminated Ligands

Metal Complexes

Iodinated Polymers

X-ray Radiology

Diagnostic Compositions

Contrast Media

NMR Contrast Agents

Nitrogenous Macrocyclic Ligands

Ionic Polyiodo Benzene

Polyiodinated Compounds

Gadolinium-DOTA Complex

Radiographic Imaging

25 patents: Sort by Forward Citations

1. 5919432 - Polyaminated ligands and metal complexes thereof (1999-07-06),

2. 5886169 - Iodinated polymers, processes for preparing them and their applications (1999-03-23),

3. 5886158 - Metal complexes of polyamino oxides, and their utilization in diagnostic (1999-03-23),

4. 5871713 - Macromolecular polyamine iodine-containing compound, process for its (1999-02-16),

5. 5851511 - Polyiodo compounds, their preparation and their use in X-ray radiology (1998-12-22),

6. 5817873 - Polyiodinated compounds, their preparation and their use as contrast (1998-10-06),

7. 5712389 - Polyaminated ligands and metal complexes thereof (1998-01-27),

8. 5709846 - Iodinated derivatives, their preparation and their use as contrast (1998-01-20),

9. 5693311 - Polyiodinated compounds, process for preparing them and diagnostic (1997-12-02),

10. 5645818 - Diagnostic compositions comprising a complex formed by a nitrogenous (1997-07-08),

11. 5618977 - Polyiodinated compounds, process of preparation and contrast agent (1997-04-08),

12. 5616798 - Poly-iodinated compounds, process for their preparation, contrast medium (1997-04-01),

13. 5609851 - Compounds which can be used in contrast products for radiography (1997-03-11),

14. 5545397 - Contrast agents and compositions for radiological imaging, and (1996-08-13),

15. 5516503 - Diagnostic composition comprising a binuclear complex, its method of (1996-05-14),

Company Overview

Guerbet S.a. is a global leader in medical imaging, specializing in the development and manufacturing of contrast agents and medical devices used in various imaging modalities. The company focuses on enhancing diagnostic capabilities in radiology and interventional procedures, providing innovative solutions that improve patient outcomes. With a strong commitment to research and development, Guerbet is dedicated to advancing imaging technologies and expanding its portfolio to meet the evolving needs of healthcare professionals worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

25 Patents

#2 in Villepinte

#842 in France

#25,730 in the World

Villepinte, France

Guerbet S.a.

Forward Citations = 263

31 inventors:

Dominique Meyer (19 out of 24 patents)

Michel Schaefer (6 out of 7 patents)

Bruno Bonnemain (5 out of 8 patents)

4. Christian Simonot (5 out of 7 patents)

5. Olivier Rousseaux (4 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Guerbet S.a.. Retrieved from https://idiyas.com/company/guerbet-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…